Icosavax Inc (ICVX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: ICVX Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-02-02	2024-02-01	PS Planned sale	Simpson Adam K. Chief Executive Officer Executive Director	15,000 -4.0% 15.29 USD 229,386	15,000 -4.0%	15.29	USD 229,386
2024-01-04	2024-01-02	PS Planned sale	Simpson Adam K. Chief Executive Officer Executive Director	15,000 -5.4% 15.67 USD 235,088	15,000 -5.4%	15.67	USD 235,088
2023-12-22	2023-12-21	S Sale	Simpson Adam K. Chief Executive Officer Executive Director	40,000 -13.3% 15.43 USD 617,060	40,000 -13.3%	15.43	USD 617,060
2023-12-22	2023-12-21	PS Planned sale	Simpson Adam K. Chief Executive Officer Executive Director	50,000 -14.3% 15.44 USD 772,220	50,000 -14.3%	15.44	USD 772,220
2023-12-22	2023-12-20	PS Planned sale	Kanesa-thasan Niranjan Chief Medical Officer Officer	11,884 -5.0% 15.46 USD 183,692	11,884 -5.0%	15.46	USD 183,692
2023-12-22	2023-12-20	S Sale	Russo Thomas Joseph Chief Financial Officer Officer	4,430 -10.4% 15.47 USD 68,510	4,430 -10.4%	15.47	USD 68,510
2023-12-22	2023-12-20	PS Planned sale	Russo Thomas Joseph Chief Financial Officer Officer	10,753 -20.2% 15.46 USD 166,210	10,753 -20.2%	15.46	USD 166,210
2023-12-22	2023-12-20	PS Planned sale	Simpson Adam K. Chief Executive Officer Executive Director	62,205 -25.2% 15.46 USD 961,509	62,205 -25.2%	15.46	USD 961,509
2023-12-22	2023-12-20	PS Planned sale	Cearley Cassia Chief Business Officer Officer	7,934 -5.7% 15.46 USD 122,637	7,934 -5.7%	15.46	USD 122,637
2023-12-15	2023-12-13	PS Planned sale	Cearley Cassia Chief Business Officer Officer	8,759 -6.3% 16.01 USD 140,190	8,759 -6.3%	16.01	USD 140,190
2023-08-01	2023-07-31	PS Planned sale	Russo Thomas Joseph Chief Financial Officer Officer	3,066 -6.3% 8.86 USD 27,169	3,066 -6.3%	8.86	USD 27,169
2023-08-01	2023-07-31	PS Planned sale	Simpson Adam K. Chief Executive Officer Executive Director	11,788 -4.6% 8.86 USD 104,459	11,788 -4.6%	8.86	USD 104,459
2023-08-01	2023-07-31	PS Planned sale	Cearley Cassia Chief Business Officer Officer	1,888 -1.3% 8.86 USD 16,731	1,888 -1.3%	8.86	USD 16,731
2023-08-01	2023-07-31	PS Planned sale	Kanesa-thasan Niranjan Chief Medical Officer Officer	3,323 -1.4% 8.86 USD 29,447	3,323 -1.4%	8.86	USD 29,447
2023-07-03	2023-07-03	PS Planned sale	Holtzman Douglas Chief Scientific Officer Officer	2,095 -0.7% 9.59 USD 20,083	2,095 -0.7%	9.59	USD 20,083
2023-07-03	2023-07-03	PS Planned sale	Holtzman Douglas Chief Scientific Officer Officer	14,261 -4.7% 8.74 USD 124,660	14,261 -4.7%	8.74	USD 124,660
2023-05-25	2023-05-23	PS Planned sale	Cearley Cassia Chief Business Officer Officer	10,000 -6.6% 10.00 USD 100,000	10,000 -6.6%	10.00	USD 100,000
2023-04-05	2023-04-03	PS Planned sale	Holtzman Douglas Chief Scientific Officer Officer	300 -0.1% 6.56 USD 1,968	300 -0.1%	6.56	USD 1,968
2023-04-05	2023-04-03	PS Planned sale	Holtzman Douglas Chief Scientific Officer Officer	20,143 -6.5% 6.08 USD 122,439	20,143 -6.5%	6.08	USD 122,439
2023-03-08	2023-03-06	PS Planned sale	Cearley Cassia Chief Business Officer Officer	5,000 -3.2% 7.75 USD 38,737	5,000 -3.2%	7.75	USD 38,737
2023-02-15	2023-02-14	PS Planned sale	Holtzman Douglas Chief Scientific Officer Officer	3,349 -1.1% 10.17 USD 34,064	3,349 -1.1%	10.17	USD 34,064
2023-02-15	2023-02-13	PS Planned sale	Holtzman Douglas Chief Scientific Officer Officer	1,522 -0.5% 10.69 USD 16,274	1,522 -0.5%	10.69	USD 16,274
2023-02-15	2023-02-13	PS Planned sale	Simpson Adam K. Chief Executive Officer Executive Director	7,506 -3.0% 10.69 USD 80,259	7,506 -3.0%	10.69	USD 80,259
2023-02-15	2023-02-13	PS Planned sale	Russo Thomas Joseph Chief Financial Officer Officer	1,902 -3.8% 10.69 USD 20,337	1,902 -3.8%	10.69	USD 20,337
2023-02-15	2023-02-13	PS Planned sale	Cearley Cassia Chief Business Officer Officer	1,660 -1.0% 10.69 USD 17,750	1,660 -1.0%	10.69	USD 17,750
2023-02-15	2023-02-13	PS Planned sale	Bekiroglu Elizabeth General Counsel & Corp. Sec. Officer	5,922 -5.4% 10.69 USD 63,322	5,922 -5.4%	10.69	USD 63,322
2023-02-15	2023-02-13	PS Planned sale	Kanesa-thasan Niranjan Chief Medical Officer Officer	1,794 -0.7% 10.69 USD 19,183	1,794 -0.7%	10.69	USD 19,183
2024-01-05	2023-01-04	S Sale	Kanesa-thasan Niranjan Chief Medical Officer Officer	106,373 -32.2% 15.70 USD 1,670,460	106,373 -32.2%	15.70	USD 1,670,460
2022-12-23	2022-12-21	PS Planned sale	Simpson Adam K. Chief Executive Officer Executive Director	66,764 -22.9% 8.96 USD 598,406	66,764 -22.9%	8.96	USD 598,406
2022-12-16	2022-12-15	S Sale	Holtzman Douglas Chief Scientific Officer Officer	19,648 -87.6% 11.14 USD 218,963	19,648 -87.6%	11.14	USD 218,963
2022-09-09	2022-09-08	PS Planned sale	Bekiroglu Elizabeth General Counsel & Corp. Sec. Officer	1,813 -1.6% 4.87 USD 8,835	1,813 -1.6%	4.87	USD 8,835
2022-08-02	2022-08-02	PS Planned sale	Russo Thomas Joseph Chief Financial Officer Officer	495 -1.0% 6.70 USD 3,318	495 -1.0%	6.70	USD 3,318
2022-08-02	2022-08-02	PS Planned sale	Richardson Charles E SVP, Technical Operations Officer	371 -0.2% 6.70 USD 2,487	371 -0.2%	6.70	USD 2,487
2022-08-02	2022-08-02	PS Planned sale	Kanesa-thasan Niranjan Chief Medical Officer Officer	543 -0.2% 6.70 USD 3,640	543 -0.2%	6.70	USD 3,640
2022-08-02	2022-08-02	PS Planned sale	Simpson Adam K. Chief Executive Officer Executive Director	1,904 -0.6% 6.70 USD 12,764	1,904 -0.6%	6.70	USD 12,764
2022-08-02	2022-08-02	PS Planned sale	Cearley Cassia Chief Business Officer Officer	303 -0.2% 6.70 USD 2,031	303 -0.2%	6.70	USD 2,031
2022-08-02	2022-08-02	PS Planned sale	Holtzman Douglas Chief Scientific Officer Officer	453 -0.2% 6.70 USD 3,037	453 -0.2%	6.70	USD 3,037
2022-08-02	2022-08-01	PS Planned sale	Russo Thomas Joseph Chief Financial Officer Officer	1,825 -3.6% 6.64 USD 12,113	1,825 -3.6%	6.64	USD 12,113
2022-08-02	2022-08-01	PS Planned sale	Richardson Charles E SVP, Technical Operations Officer	1,368 -0.8% 6.64 USD 9,080	1,368 -0.8%	6.64	USD 9,080
2022-08-02	2022-08-01	PS Planned sale	Kanesa-thasan Niranjan Chief Medical Officer Officer	2,001 -0.8% 6.64 USD 13,281	2,001 -0.8%	6.64	USD 13,281
2022-08-02	2022-08-01	PS Planned sale	Simpson Adam K. Chief Executive Officer Executive Director	7,017 -2.3% 6.64 USD 46,575	7,017 -2.3%	6.64	USD 46,575
2022-08-02	2022-08-01	PS Planned sale	Cearley Cassia Chief Business Officer Officer	1,118 -0.8% 6.64 USD 7,421	1,118 -0.8%	6.64	USD 7,421
2022-08-02	2022-08-01	PS Planned sale	Holtzman Douglas Chief Scientific Officer Officer	9,337 -3.1% 6.64 USD 61,973	9,337 -3.1%	6.64	USD 61,973
2022-08-02	2022-07-29	PS Planned sale	Russo Thomas Joseph Chief Financial Officer Officer	639 -1.2% 7.11 USD 4,542	639 -1.2%	7.11	USD 4,542
2022-08-02	2022-07-29	PS Planned sale	Richardson Charles E SVP, Technical Operations Officer	479 -0.3% 7.11 USD 3,405	479 -0.3%	7.11	USD 3,405
2022-08-02	2022-07-29	PS Planned sale	Kanesa-thasan Niranjan Chief Medical Officer Officer	701 -0.3% 7.11 USD 4,982	701 -0.3%	7.11	USD 4,982
2022-08-02	2022-07-29	PS Planned sale	Simpson Adam K. Chief Executive Officer Executive Director	2,456 -0.8% 7.11 USD 17,456	2,456 -0.8%	7.11	USD 17,456
2022-08-02	2022-07-29	PS Planned sale	Cearley Cassia Chief Business Officer Officer	391 -0.3% 7.11 USD 2,779	391 -0.3%	7.11	USD 2,779
2022-08-02	2022-07-29	PS Planned sale	Holtzman Douglas Chief Scientific Officer Officer	585 -0.2% 7.11 USD 4,158	585 -0.2%	7.11	USD 4,158
2022-04-05	2022-04-01	B Purchase	MCDADE MARK Non-Executive Director	42,225 +526.6% 7.10 USD 299,798	42,225 +526.6%	7.10	USD 299,798
2022-03-30	2022-03-29	B Purchase	RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder	8,900 +0.1% 4.75 USD 42,271	8,900 +0.1%	4.75	USD 42,271
2022-03-30	2022-03-28	B Purchase	RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder	175,318 +3.0% 4.53 USD 794,611	175,318 +3.0%	4.53	USD 794,611
2022-03-09	2022-03-07	PS Planned sale	Cearley Cassia Chief Business Officer Officer	484 -0.5% 17.81 USD 8,620	484 -0.5%	17.81	USD 8,620
2022-03-09	2022-03-07	PS Planned sale	Cearley Cassia Chief Business Officer Officer	9,516 -8.8% 17.13 USD 163,009	9,516 -8.8%	17.13	USD 163,009
2021-08-03	2021-08-02	B Purchase	Gould Terry P Non-Executive Director	12,368 +5.1% 15.00 USD 185,520	12,368 +5.1%	15.00	USD 185,520
2021-08-03	2021-08-02	B Purchase	Gould Terry P Non-Executive Director	26,604 +5.1% 15.00 USD 399,060	26,604 +5.1%	15.00	USD 399,060
2021-08-03	2021-08-02	B Purchase	Gould Terry P Non-Executive Director	46,381 +5.1% 15.00 USD 695,715	46,381 +5.1%	15.00	USD 695,715
2021-08-03	2021-08-02	B Purchase	Gould Terry P Non-Executive Director	47,981 +5.1% 15.00 USD 719,715	47,981 +5.1%	15.00	USD 719,715
2021-08-02	2021-08-02	B Purchase	Sanofi Large shareholder	66,667 +2.2% 15.00 USD 1,000,005	66,667 +2.2%	15.00	USD 1,000,005

Icosavax Inc (ICVX)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by